These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1344865)

  • 1. [Methodology for quality control of an ointment with antivaricose properties].
    Lazăr D; Lazăr MI; Verbuţă A; Dănilă G; Oiţă N
    Rev Med Chir Soc Med Nat Iasi; 1992; 96(3-4):253-6. PubMed ID: 1344865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Supportive drug therapy of varicose veins with venelbin].
    Ohler R
    Fortschr Med; 1978 Nov; 96(42):2173-7. PubMed ID: 711110
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-statistical study on the activity of a phlebo-active drug Fleboplex in obstetrical and gynecologic pathology].
    Ricci MG
    Minerva Ginecol; 1974 Nov; 26(11):641-6. PubMed ID: 4444806
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the trial of a new antivaricose agent in clinical patients].
    Riebenbauer W
    Hippokrates; 1968 May; 39(10):384-9. PubMed ID: 5715045
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sense and nonsense of antivaricose agents].
    Salfeld K
    Z Haut Geschlechtskr; 1969 Sep; 44(18):713-26. PubMed ID: 5382940
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sclerosing of varicose veins and additional medication. Are disease course and results affected by combined therapy? An experience report].
    Böhme D
    ZFA (Stuttgart); 1980 May; 56(13):953-9. PubMed ID: 7415464
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analytical study of theophylline-rutozide (TR-1722)].
    Lazăr MI; Lazăr D; Dănilă G
    Rev Med Chir Soc Med Nat Iasi; 1992; 96(3-4):243-8. PubMed ID: 1344863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EXPERIENCES IN THE USE OF VENORUTON-P4 OINTMENT].
    WEITGASSER H
    Wien Med Wochenschr; 1965 Mar; 115():271-3. PubMed ID: 14311494
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quality control by physicochemical methods of prepared drug forms containing corticosteroids. I. The spectrophotometric determination of hydrocortisone acetate in an ointment].
    Bobkova LN; Kazarinov NA
    Farm Zh; 1973; 28(6):29-33. PubMed ID: 4792450
    [No Abstract]   [Full Text] [Related]  

  • 10. [The physicochemical characterization and therapeutic evaluation of Cicatrol].
    Popovici I; Dănila G; Oiţă N; Dima F; Vasilescu M; Dorneanu V; Lazăr D; Caraman C; Braha S; Popovici AT
    Rev Med Chir Soc Med Nat Iasi; 1992; 96(1-2):57-64. PubMed ID: 1410926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience with a new compound with vasodynamic and capillaroprotective action in the treatment of venous diseases of the lower limbs].
    Bagliani A; Vittori F
    Minerva Cardioangiol; 1972; 20(7):390-6. PubMed ID: 5050746
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy of venopathies].
    Esser W
    Fortschr Med; 1975 Oct; 93(30):1506-7. PubMed ID: 1225812
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical experience in testing of various ointment for treatment of the varicose symptom complex].
    Kinscher K; Trentmann M
    Landarzt; 1967 Jul; 43(20):973-7. PubMed ID: 5616143
    [No Abstract]   [Full Text] [Related]  

  • 14. [Heparin ointment in the treatment of thrombophlebitis].
    Balogh P
    Orv Hetil; 1965 Nov; 106(48):2279-80. PubMed ID: 5852913
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical test of the new antivaricose agent BayroVas].
    Berger H; Derra A
    Med Welt; 1972 Apr; 23(15):560-3. PubMed ID: 4402616
    [No Abstract]   [Full Text] [Related]  

  • 16. Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments.
    Xu X; Al-Ghabeish M; Rahman Z; Krishnaiah YS; Yerlikaya F; Yang Y; Manda P; Hunt RL; Khan MA
    Int J Pharm; 2015 Sep; 493(1-2):412-25. PubMed ID: 26231106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new antivaricose drug in the varicose symptom complex and in hemorrhoids].
    Müller HK
    Med Klin; 1968 May; 63(18):724-7. PubMed ID: 5719911
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prolonged clinical study of the LA, 313-B-xanthinol niacinate pentosan sulfonate ester combination in various forms of hypertension].
    Masso M; Gimeno Martínez J; Honorato J
    Rev Clin Esp; 1976 Jul; 142(2):157-61. PubMed ID: 968103
    [No Abstract]   [Full Text] [Related]  

  • 19. Symptomatic relief of the pre-varicose syndrome and the symptomatology associated with varicose veins using ergot compounds.
    Gordon JA
    Cent Afr J Med; 1972 Nov; 18(11):219-21. PubMed ID: 4205180
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biologic methods of evaluation of ointments and ointment bases].
    Mandak M; Kuchera I; Veber V
    Farmatsiia; 1969; 18(2):73-9. PubMed ID: 4893500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.